LUV-TRAIL loaded with doxorubicin (Dox) in the liposomal lumen, known as LUVDOX-TRAIL, improved cytotoxic potential by enhanced caspase-8 activation in the tumor xenograft model of breast cancer cells[113]. The gene discussed is TNFSF10; the disease is neoplasm.